RLMD RELMADA THERAPEUTICS, INC.: institutional ownership and insider trading
132 funds reported holding $778M of RELMADA THERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net bought $105M, with 46 new positions and 23 funds selling out; over the last 12 months insiders bought $4.03M and sold $0 on the open market.
RLMD revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$12.9M, EPS -0.11
- Quarter ended Mar 31, 2026: revenue n/a, net income −$19.1M, EPS -0.22
- Quarter ended Dec 31, 2025: revenue n/a, net income $37.5M, EPS -0.27
- Quarter ended Sep 30, 2025: revenue n/a, net income −$10.1M, EPS -0.30
Famous investors holding RLMD
- Izzy Englander (Millennium Management): $16.3M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $8.10M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.49M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $758K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $400K, 0.0% of the portfolio
Largest institutional holders of RLMD
- Jupiter Topco LLC — $77.3M
- JANUS HENDERSON GROUP PLC (JHG) — $76.9M
- BlackRock, Inc. (BLK) — $51.4M
- Squadron Capital Management LLC — $50.9M
- VR Adviser, LLC — $47.4M
- Spruce Street Capital LP — $44.2M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $33.0M
- VANGUARD CAPITAL MANAGEMENT LLC — $30.9M
- Jones Hill Capital LP — $25.3M
- ORBIMED ADVISORS LLC — $25.1M
Recent RLMD insider trades
- Sep 10, 2026: Traversa Sergio bought 200,000 shares ($828K)
- Sep 10, 2026: Shenouda Maged bought 200,000 shares ($844K)
- Dec 15, 2025: Shenouda Maged bought 11,665 shares ($48.1K)
- Dec 15, 2025: Traversa Sergio bought 27,500 shares ($113K)
5%+ owners
- BlackRock, Inc.: 7.0% (Schedule 13G, filed Jul 29, 2026)
- Squadron Master Fund LP: 7.0% (Schedule 13G/A, filed Aug 14, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 6.2% (Schedule 13G, filed Jun 9, 2026)
- Commodore Capital LP: 5.1% (Schedule 13G, filed May 4, 2026)